SBI Contra Fund Direct Growth NAV Falls to ₹403.77 on 15 September; 5-Year CAGR at 15.30%

Key Takeaways

• SBI Contra Fund Direct Growth NAV declined 1.27% to ₹403.77 on 15 September 2026.
• The one-year return stood at -1.95%, compared with a 10.44% three-year CAGR and a 15.30% five-year CAGR.
• The scheme managed approximately ₹47,589 crore, with a Direct Growth expense ratio of 0.86%.
• TREPS and the four largest disclosed equity positions together accounted for 24.42% of the portfolio.

SBI Contra Fund Direct Growth NAV declined 1.27% to ₹403.77 on 15 September 2026. Its latest one-year return stood at -1.95%. Across the three-year measurement period, the fund recorded an annualised return of 10.44%, creating a clear difference between the recent trailing year and the medium-term historical record.

The five-year CAGR was higher at 15.30%. It exceeded the three-year figure by 4.86 percentage points and stood 17.25 percentage points above the latest one-year return. Each return period starts from a different historical NAV, which makes the figures separate measurements rather than stages of a uniform performance path.

Assets under management stood at approximately ₹47,589 crore. The Direct Growth expense ratio was 0.86%. Minimum SIP investment was ₹500, while the minimum lump-sum amount stood at ₹5,000.

TREPS was the largest disclosed portfolio allocation at 7.11%. Reliance Industries was the largest listed equity holding at 4.75%, followed by ICICI Bank at 4.55% and HDFC Bank at 4.54%. Biocon accounted for another 3.47%. Including TREPS, those five disclosed entries represented 24.42% of the portfolio. TREPS is a money-market exposure and should therefore be distinguished from the scheme's equity holdings.

Historical risk readings included beta of 0.98 and standard deviation of 4.06. Alpha stood at 6.34, with the Sharpe ratio at 0.55. The exit-load structure is tiered: the charge is 0.25% for exits within 30 days, 0.10% after 30 days but within 90 days, and nil thereafter. These are historical and structural measures rather than indicators of future returns.